Showing 1491-1500 of 23118 results for "".
Potassium Binders: Safety Comes First!
https://reachmd.com/programs/cme/tbd/37673/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
https://reachmd.com/programs/cme/tbd/37674/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
https://reachmd.com/programs/cme/tbd/36194/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Future Directions in Managing Hyperkalemia in CKD and HF
https://reachmd.com/programs/cme/tbd/37676/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
https://reachmd.com/programs/cme/breaking-ground-2025-milestones-in-cushing-syndrome-and-looking-forward-to-2026/50059/2025 delivered an expanded approval for Cushing syndrome for one agent, a complete response letter for another, and deeper insights on the prevalence of Cushing syndrome (or hypercortisolism) in people with difficult-to-control metabolic conditions. 2026 promises to be jam packed with further insighA Look at Lipoprotein(a): Key Screening & Treatment Strategies
https://reachmd.com/programs/heart-matters/a-look-at-lipoproteina-key-screening-treatment-strategies/14992/Which of our patients should we screen for lp(a)? And what treatment options are available?Patients’ Overall Skin Health Needs: Treating the Aesthetic Patient
https://modernaesthetics.com/topics/skincare/patients-overall-skin-health-needs-treating-the-aesthetic-patient/35160/A look at the role aesthetic physicians can play in helping to manage patients’ medical dermatologic conditionsTitrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
https://reachmd.com/programs/cme/titrating-and-dosing-device-therapy-for-dre-best-practices-for-optimizing-patient-outcomes/14854/How do you titrate & dose a patient on VNS therapy? Experts discuss best practices in adult & pediatric patients with add-on neuromodulation for DRE.Duchenne Muscular Dystrophy: Approaches to Care
https://reachmd.com/programs/clinicians-roundtable/duchenne-muscular-dystrophy-approaches-to-care/477/Dr. Brenda Wong, Associate Professor of Pediatrics and Neurology and Director of the Neuromuscular Comprehensive Care Center at Cincinnati Children's Hospital Medical Center talks about the latest treatments and the economics of effectively treating children with chronic illness, with special focusThe Importance of the Atopic Dermatitis Pipeline
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37148/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, provides an overview of important research underway involving new therapeutics for the treatment of atop